A5418 is a randomized, placebo-controlled, double-blind study to establish the efficacy of tecovirimat for the treatment of people with laboratory-confirmed or presumptive HMPXV disease.
Age: Birth - 66+
Gender: All
We've found 1 total result for "Monkeypox".